Clinical Trial Reports are formal documents summarizing the results of clinical studies conducted to evaluate the efficacy and safety of pharmaceuticals, vaccines, and medical devices that are applied directly to the human body. These include a range of documents such as clinical trial protocols, Phase I/II/III trial results, interim reports, and final study reports. They must adhere to standardized structures and terminology required by regulatory agencies such as the FDA (U.S.), EMA (Europe), and MFDS (Republic of Korea).

Translation must accurately convey detailed information, including pharmacological data, test design, subject demographics, statistical analyses, and adverse event reporting. These documents require a writing style that is both academic and regulatory in nature.

Translators must possess a deep understanding of clinical pharmacology, medicine, and statistics, and be well-versed in clinical trial processes and relevant international regulations to ensure precision and compliance.